Portland Global Advisors’s Merck MRK Stock Holding History

Portland Global Advisors’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.52M	Buy	12,606 +448	+4%	+$51.7K	0.16%	66
2025 Q4	$1.28M	Sell	12,158 -175	-1%	-$16.4K	0.14%	69
2025 Q3	$1.04M	Sell	12,333 -588	-5%	-$48.4K	0.12%	71
2025 Q2	$1.02M	Sell	12,921 -61	-0.5%	-$4.85K	0.12%	71
2025 Q1	$1.17M	Hold	12,982	–	–	0.15%	65
2024 Q4	$1.29M	Sell	12,982 -1,407	-10%	-$145K	0.16%	65
2024 Q3	$1.63M	Sell	14,389 -75	-0.5%	-$8.91K	0.21%	61
2024 Q2	$1.79M	Sell	14,464 -300	-2%	-$38.6K	0.24%	56
2024 Q1	$1.95M	Sell	14,764 -333	-2%	-$41K	0.27%	53
2023 Q4	$1.65M	Hold	15,097	–	–	0.25%	57
2023 Q3	$1.55M	Hold	15,097	–	–	0.26%	59
2023 Q2	$1.74M	Sell	15,097 -61	-0.4%	-$6.93K	0.29%	55
2023 Q1	$1.61M	Sell	15,158 -37	-0.2%	-$4K	0.28%	62
2022 Q4	$1.69M	Sell	15,195 -30	-0.2%	-$3.07K	0.31%	62
2022 Q3	$1.31M	Buy	15,225 +40	+0.3%	+$3.57K	0.26%	65
2022 Q2	$1.38M	Buy	15,185 +92	+0.6%	+$8.16K	0.27%	63
2022 Q1	$1.24M	Hold	15,093	–	–	0.21%	70
2021 Q4	$1.16M	Sell	15,093 -10	-0.1%	-$796	0.19%	71
2021 Q3	$1.13M	Hold	15,103	–	–	0.21%	69
2021 Q2	$1.18M	Sell	15,103 -514	-3%	-$38.2K	0.23%	66
2021 Q1	$1.15M	Hold	15,617	–	–	0.24%	64
2020 Q4	$1.22M	Hold	15,617	–	–	0.3%	58
2020 Q3	$1.24M	Buy	15,617 +139	+0.9%	+$10.9K	0.36%	48
2020 Q2	$1.14M	Hold	15,478	–	–	0.37%	49
2020 Q1	$1.14M	Sell	15,478 -38	-0.2%	-$2.99K	0.44%	45
2019 Q4	$1.35M	Sell	15,516 -466	-3%	-$38.3K	0.4%	47
2019 Q3	$1.28M	Sell	15,982 -2,171	-12%	-$174K	0.43%	45
2019 Q2	$1.45M	Buy	18,153 +427	+2%	+$32.7K	0.48%	42
2019 Q1	$1.41M	Buy	17,726 +215	+1%	+$16.1K	0.49%	41
2018 Q4	$1.28M	Sell	17,511 -330	-2%	-$23.3K	0.51%	40
2018 Q3	$1.21M	Sell	17,841 -5	-0%	-$319	0.43%	43
2018 Q2	$1.03M	Buy	17,846 +1,062	+6%	+$59.9K	0.39%	45
2018 Q1	$872K	Sell	16,784 -209	-1%	-$11.3K	0.33%	49
2017 Q4	$912K	Sell	16,993 -7,890	-32%	-$437K	0.34%	48
2017 Q3	$1.52M	Hold	24,883	–	–	0.58%	39
2017 Q2	$1.52M	Hold	24,883	–	–	0.61%	37
2017 Q1	$1.51M	Sell	24,883 -382	-2%	-$23.2K	0.63%	37
2016 Q4	$1.42M	Buy	25,265 +31	+0.1%	+$1.81K	0.62%	39
2016 Q3	$1.5M	Sell	25,234 -230	-0.9%	-$13.4K	0.66%	39
2016 Q2	$1.4M	Sell	25,464 -1,599	-6%	-$85.1K	0.64%	42
2016 Q1	$1.37M	Buy	27,063 +210	+0.8%	+$10.3K	0.65%	42
2015 Q4	$1.35M	Sell	26,853 -288	-1%	-$14.5K	0.73%	41
2015 Q3	$1.28M	Sell	27,141 -360	-1%	-$19.1K	0.75%	39
2015 Q2	$1.49M	Buy	27,501 +1,452	+6%	+$81.4K	0.78%	35
2015 Q1	$1.43M	Hold	26,049	–	–	0.74%	38
2014 Q4	$1.41M	Sell	26,049 -707	-3%	-$39.4K	0.73%	41
2014 Q3	$1.51M	Sell	26,756 -200	-0.7%	-$11.2K	0.78%	36
2014 Q2	$1.49M	Sell	26,956 -145	-0.5%	-$7.91K	0.75%	37
2014 Q1	$1.47M	Sell	27,101 -771	-3%	-$39.9K	0.86%	31
2013 Q4	$1.33M	Sell	27,872 -497	-2%	-$22.7K	0.83%	33
2013 Q3	$1.29M	Sell	28,369 -498	-2%	-$22.7K	0.87%	32
2013 Q2	$1.28M	Buy	+28,867	New	+$1.29M	0.91%	30

Other funds holding MRK

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Portland Global Advisors's MRK Position: Q1 2026 in Review

Portland Global Advisors increased its Merck (MRK) stake by 3.7% in Q1 2026, buying an estimated $51.7K and bringing the position to 12,606 shares worth $1.52M. The position accounts for 0.16% of the portfolio, ranked #66.

Portland Global Advisors first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.95M in Q1 2024. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

Portland Global Advisors held 12,606 shares of Merck worth $1.52M as of Q1 2026.
Portland Global Advisors bought 448 Merck shares in Q1 2026, an estimated $51.7K.
Merck made up 0.16% of Portland Global Advisors's portfolio in Q1 2026, its #66 holding.
Portland Global Advisors first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
Portland Global Advisors's Merck position peaked at $1.95M in Q1 2024.
3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Portland Global Advisors's 13F filing for Q1 2026, filed 11 May 2026.